Astera Labs (NASDAQ:ALAB – Get Free Report) issued an update on its third quarter 2026 earnings guidance on Tuesday morning. The company provided earnings per share guidance of 1.160-1.210 for the period, compared to the consensus EPS estimate of 0.730. The company issued revenue guidance of $540.0 million-$560.0 million, compared to the consensus revenue estimate of $410.3 million.
Wall Street Analyst Weigh In
Several equities research analysts recently weighed in on the stock. Evercore reaffirmed an “outperform” rating and set a $297.00 target price on shares of Astera Labs in a research note on Tuesday, May 19th. Roth Capital reaffirmed a “buy” rating and set a $450.00 price objective on shares of Astera Labs in a research report on Wednesday. TD Cowen reaffirmed a “hold” rating on shares of Astera Labs in a research report on Wednesday. Weiss Ratings upgraded shares of Astera Labs from a “hold (c-)” rating to a “hold (c)” rating in a research note on Thursday, May 21st. Finally, JPMorgan Chase & Co. lifted their price target on shares of Astera Labs from $205.00 to $280.00 and gave the stock an “overweight” rating in a research note on Wednesday, May 6th. Thirteen research analysts have rated the stock with a Buy rating and ten have given a Hold rating to the company. According to MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and a consensus price target of $327.75.
Get Our Latest Stock Report on ALAB
Astera Labs Price Performance
Astera Labs (NASDAQ:ALAB – Get Free Report) last released its earnings results on Tuesday, August 4th. The company reported $0.80 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.69 by $0.11. The company had revenue of $392.40 million for the quarter, compared to analysts’ expectations of $360.85 million. Astera Labs had a return on equity of 18.49% and a net margin of 26.72%.The firm’s quarterly revenue was up 104.5% on a year-over-year basis. During the same quarter in the previous year, the firm posted $0.44 EPS. Astera Labs has set its Q3 2026 guidance at 1.160-1.210 EPS. On average, equities analysts anticipate that Astera Labs will post 1.86 EPS for the current fiscal year.
Insider Transactions at Astera Labs
In other Astera Labs news, Director Bethany Mayer sold 686 shares of the business’s stock in a transaction on Wednesday, June 24th. The stock was sold at an average price of $395.04, for a total value of $270,997.44. Following the completion of the transaction, the director directly owned 5,550 shares in the company, valued at approximately $2,192,472. The trade was a 11.00% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is accessible through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Stefan A. Dyckerhoff sold 3,505 shares of the stock in a transaction dated Wednesday, July 1st. The stock was sold at an average price of $450.00, for a total value of $1,577,250.00. Following the transaction, the director owned 57,466 shares in the company, valued at $25,859,700. This trade represents a 5.75% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders sold 1,676,845 shares of company stock worth $444,928,806 in the last 90 days. Insiders own 10.40% of the company’s stock.
Astera Labs News Summary
Here are the key news stories impacting Astera Labs this week:
- Positive Sentiment: Q2 results significantly exceeded expectations: Revenue reached a record $392.4 million, up 104.5% year over year and 27% sequentially, while earnings per share of $0.80 surpassed the $0.69 consensus estimate. Astera Labs Reports Second Quarter 2026 Financial Results
- Positive Sentiment: Q3 outlook was far above analyst forecasts: Astera Labs guided for revenue of $540 million to $560 million and EPS of $1.16 to $1.21, compared with consensus estimates of $410.3 million and $0.73, respectively. The outlook implies roughly 40% sequential revenue growth. Astera Labs Sees Revenue Jumping 40% Next Quarter
- Positive Sentiment: Scorpio X-Series momentum is accelerating: The 320-lane fabric switch entered volume production one quarter ahead of schedule and is expected to be a major Q3 growth driver. PCIe 6 products now account for more than half of revenue, reflecting strong AI infrastructure demand. ALAB Q2 Earnings Call Puts Scorpio Ramp Ahead of Schedule
- Positive Sentiment: Analyst sentiment improved: Needham raised its price target to $425 and maintained a Buy rating, while other analysts increased forecasts following the earnings report. Needham Raises Astera Labs Price Target
- Negative Sentiment: Valuation and expectations remain concerns: With the stock trading at a very high earnings multiple after a substantial run-up, one analyst downgraded the shares, arguing that the “easy money” phase is over. Investors may be taking profits despite the strong fundamentals and demanding guidance. Astera Labs Rating Downgrade
Institutional Investors Weigh In On Astera Labs
Several institutional investors have recently bought and sold shares of ALAB. Smartleaf Asset Management LLC grew its position in Astera Labs by 422.2% in the fourth quarter. Smartleaf Asset Management LLC now owns 188 shares of the company’s stock valued at $32,000 after acquiring an additional 152 shares in the last quarter. Towarzystwo Funduszy Inwestycyjnych PZU SA acquired a new position in shares of Astera Labs during the fourth quarter worth $33,000. Wexford Capital LP purchased a new position in shares of Astera Labs in the third quarter valued at $39,000. National Bank of Canada FI boosted its stake in shares of Astera Labs by 159.0% in the third quarter. National Bank of Canada FI now owns 202 shares of the company’s stock valued at $39,000 after purchasing an additional 124 shares during the period. Finally, Silicon Valley Capital Partners acquired a new stake in Astera Labs during the 4th quarter valued at $50,000. 60.47% of the stock is currently owned by hedge funds and other institutional investors.
About Astera Labs
Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.
The company’s product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.
Featured Stories
- Five stocks we like better than Astera Labs
- Meta’s Earnings Drop Shows Wall Street Wants More Than Ad Growth
- AMD’s Post-Earnings Drop May Be the Opportunity Investors Wanted
- 3 Stocks That Prove the AI Trade Isn’t Over, It Moved
- The FTC Is Suing Hims & Hers Health—Here’s Why Investors Shouldn’t Panic
Receive News & Ratings for Astera Labs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Astera Labs and related companies with MarketBeat.com's FREE daily email newsletter.
